companies > I > Ipca Laboratories Ipca Laboratories Global Fund stops sourcing IPCA's anti-malaria drug 08 April 2016 Ipca to make open offer for 26% stake in Krebs on 9 November 04 November 2015 Canadian regulator asks Ipca to stop API exports 22 September 2014 Ipca Labs looks to acquire pharma unit in Indonesia 28 September 2011 Ipca Labs buys UK-based Onyx Research Chemicals 09 August 2011 Ipca Labs, US-based Heritage to market cardiovascular tablet, Propranolol in the US 13 October 2008 Ipca''s anti-malarial product Artesunate pre-qualified by WHO 15 September 2007 Ipca-Ranbaxy alliance to market Metformin HCL tablets in US 14 August 2007 Ipca - Ranbaxy alliance receive US FDA marketing approval for atenolol tablets 02 January 2007 Ipca's 'Atenolol' bulk drug registered in China 29 December 2006 IPCA phases out single ingredient malarial drug; launches India's first ACT 06 October 2006 Ipca Laboratories in marketing alliance with Ranbaxy for US sales 21 September 2006 Ipca launches India's first novel injectible antibiotic combination 20 May 2004  search domain-b    go
Legal Policy | Copyright © 1999-2016 The Information Company Private Limited. All rights reserved.